Medical Devices Companies By Enterprise Value
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Current Valuation
| Current Valuation | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | BBNX | Beta Bionics, Common | (0.31) | 2.68 | (0.84) | ||
| 2 | CBLL | CeriBell, | (0.05) | 3.43 | (0.17) | ||
| 3 | BDMD | Baird Medical Investment | 0.11 | 82.95 | 9.27 | ||
| 4 | NAYA | NAYA Biosciences, | (0.17) | 7.57 | (1.32) | ||
| 5 | NUVO | Holdco Nuvo Group | 0.12 | 34.18 | 3.99 | ||
| 6 | BSGM | BioSig Technologies, Common | (0.04) | 9.84 | (0.42) |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.